---
title: "Decorous Investment And Trading Co Ltd (539405) — Share Price, Financials & Analysis"
symbol: "539405"
company: "Decorous Investment And Trading Co Ltd"
canonical: "https://tapetide.com/stocks/539405"
isin: "INE183R01010"
nse_symbol: "DECOROUSINVESTMENTTRADINGCOLTD"
bse_code: "539405"
sector: "Consumer Goods"
industry: "Jewellery & Watches"
market_cap_cr: 4.93
generated_at: "2026-09-13T18:58:41.437Z"
---

# Decorous Investment And Trading Co Ltd (539405)

Canonical page: https://tapetide.com/stocks/539405

## Company

- **NSE Symbol:** DECOROUSINVESTMENTTRADINGCOLTD
- **BSE Code:** 539405
- **ISIN:** INE183R01010
- **Sector:** Consumer Goods
- **Industry:** Jewellery & Watches
- **Macro Sector:** Consumer Discretionary
- **Stock Type:** EQUITY
- **Listed Since:** 2015-10-27
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** ditco.in

## About

Incorporated in 1982, Decorous Investment 
and Trading Company Ltd deals in Real Estate, 
Consulting, Agents, and Distributors, etc.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:44:19.338684Z.

- **Market Cap:** ₹4.93 Cr
- **Classification:** Microcap
- **P/E (reported):** 108.3
- **EPS (TTM):** ₹0.11
- **Book Value:** ₹11.4
- **Price to Book:** 1.14
- **Dividend Yield:** 0%
- **ROE:** 2.67%
- **ROCE:** 3.72%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹0.6 Cr
- **Net Income:** ₹0.1 Cr
- **EBITDA:** ₹0.1 Cr
- **52-Week High:** ₹16.6
- **52-Week Low:** ₹9.19
- **RSI (14):** 58.38

## Tapetide Score

- **Score:** 43 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 22.3 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 86.47 | 9% |
| growth | 39.51 | 9% |
| momentum | 39.22 | 12% |
| ownership | 50 | 24% |
| quality | 34.06 | 22% |
| valuation | 27.82 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 1.14 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 1.27%
- Company has a low return on equity of 2.72% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 40.63% | -26.67% | -137.5% |
| ebitda margin growth | 0% | 68.25% | -29.78% | -14.97% |
| net income growth | 0% | 0% | 3% | 0% |
| revenue growth | -100% | 0% | 21% | 20% |
| roce | — | 76.3% | -27.2% | 3.48% |
| roe | — | 71.15% | 2.68% | 29.61% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.03 | 0 | 0.28 | 0 | 0 | 0.15 | 0.19 | 0.02 | 0 | 0.23 | 0.12 | 0 |
| Expenses | 0.03 | 0.03 | 0.26 | 0.03 | 0.03 | 0.18 | 0.23 | 0.03 | 0.02 | 0.22 | 0.17 | 0.03 |
| Operating Profit | 0 | -0.03 | 0.02 | -0.03 | -0.03 | -0.03 | -0.04 | -0.01 | -0.02 | 0.01 | -0.05 | -0.03 |
| OPM % | 0 | — | 7.14 | — | — | -20 | -21.05 | -50 | — | 4.35 | -41.67 | — |
| Other Income | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 | 0.05 | 0.06 | 0.01 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.05 | 0.02 | 0.08 | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.06 | 0.01 | -0.02 |
| Tax % | 0 | 0 | 62.5 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 400 | 0 |
| Net Profit | 0.05 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0 | 0.04 | 0.03 | 0.06 | -0.03 | -0.02 |
| EPS in Rs | 0.14 | 0.06 | 0.09 | 0.06 | 0.06 | 0.06 | 0 | 0.12 | 0.09 | 0.17 | -0.09 | -0.06 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.1 | 0.07 | 0.13 | 0.15 | 0.19 | 0.21 | 0.34 | 0.34 | 0.37 | 0.35 |
| Expenses | 0.13 | 0.13 | 0.24 | 0.3 | 0.25 | 0.27 | 0.37 | 0.48 | 0.45 | 0.44 |
| Operating Profit | -0.03 | -0.06 | -0.11 | -0.15 | -0.06 | -0.06 | -0.03 | -0.14 | -0.08 | -0.09 |
| OPM % | -30 | -85.71 | -84.62 | -100 | -31.58 | -28.57 | -8.82 | -41.18 | -21.62 | -25.71 |
| Other Income | 0.04 | 0.07 | 0.12 | 0.15 | 0.16 | 0.19 | 0.22 | 0.22 | 0.23 | 0.17 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.01 | 0.01 | 0.01 | 0 | 0.1 | 0.13 | 0.19 | 0.08 | 0.15 | 0.08 |
| Tax % | 0 | 0 | 0 | — | 30 | 23.08 | 26.32 | 25 | 26.67 | — |
| Net Profit | 0 | 0.01 | 0.01 | 0 | 0.07 | 0.1 | 0.14 | 0.06 | 0.11 | 0.04 |
| EPS in Rs | 0 | 0.03 | 0.03 | 0 | 0.2 | 0.29 | 0.41 | 0.17 | 0.32 | 0.11 |
| Dividend Payout % | — | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 |
| Reserves | -0.01 | -0.01 | 0 | 0 | 0 | 0.08 | 0.18 | 0.32 | 0.38 | 0.48 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | 0.04 |
| Total Liabilities | 3.44 | 3.45 | 3.46 | 3.47 | 3.47 | 3.56 | 3.65 | 3.79 | 3.84 | 3.97 |
| Fixed Assets | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 3.43 | 3.44 | 3.46 | 3.47 | 3.47 | 3.56 | 3.65 | 3.79 | 3.84 | 3.97 |
| Total Assets | 3.44 | 3.45 | 3.46 | 3.47 | 3.47 | 3.56 | 3.65 | 3.79 | 3.84 | 3.97 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.19 | -0.2 | 0.05 | -0.03 | 0.1 | -0.08 | -0.2 | -0.15 | -0.32 | -0.19 |
| Cash from Investing Activity | -0.15 | 0.15 | -0.01 | 0 | -0.1 | 0.75 | -0.46 | 0.32 | 0.2 | 0.24 |
| Cash from Financing Activity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.03 | -0.05 | 0.05 | -0.04 | 0 | 0.67 | -0.66 | 0.16 | -0.12 | 0.05 |
| Free Cash Flow | 0.19 | -0.2 | 0.05 | -0.03 | 0.1 | -0.08 | -0.2 | -0.15 | -0.32 | -0.19 |
| CFO/OP | -400 | 633 | -100 | 9 | -60 | 83 | 283 | 333 | 214 | 188 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | 0 | 0 | 252.69 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0 | — | — | — | — | — | — | 0 | 0 | 0 |
| Days Payable | — | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 0 | 0 | 0 | 252.69 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | 766.02 | 12337 | 17415.71 | 9518.08 | 170.33 | 115.26 | 295.48 | 268.38 | 450.88 | 483.38 |
| ROCE % | 0 | 0.29 | 0.29 | 0.29 | 0 | 2.87 | 3.63 | 5.14 | 2.11 | 3.87 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 1.27% | 1.27% | 1.27% | 1.27% | 1.27% | 1.27% | 1.27% | 1.27% | 1.27% | 1.27% | 1.27% | 1.27% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 94.96% | 96.4% | 95.53% | 95.53% | 97.16% | 97.31% | 97.31% | 98.04% | 97.01% | 91.63% | 94.64% | 97.01% |
| Others | 3.78% | 2.33% | 3.2% | 3.21% | 1.57% | 1.43% | 1.43% | 0.7% | 1.72% | 7.1% | 4.1% | 1.72% |
| No. of Shareholders | 1037 | 1083 | 1136 | 1237 | 1363 | 1668 | 1677 | 1677 | 1659 | 1607 | 1567 | 1597 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 5 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 12.17 | Buy |
| EMA (10) | 12.3 | Buy |
| SMA (20) | 12.06 | Buy |
| EMA (20) | 12.17 | Buy |
| SMA (50) | 12.16 | Buy |
| EMA (50) | 12.39 | Buy |
| SMA (100) | 13.11 | Sell |
| EMA (100) | 12.78 | Buy |
| SMA (200) | 13.19 | Sell |
| EMA (200) | 12.93 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 58.38 | Neutral |
| MACD (12,26,9) | 0.07 | Buy |
| Stochastic (14,3,3) | 79.97 | Neutral |
| ADX (14) | 26 | Buy |
| Williams %R (14) | -33.69 | Neutral |
| ATR (14) | 1.1 | High Volatility |
| ROC (12) | 14.24 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 54.9 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-22 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12222a1d-1ed1-4388-9ae3-975977aaedaa.pdf) |
| 2026-08-22 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c5029bc-4018-4664-8166-eca6f2f8da5d.pdf) |
| 2026-08-20 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36c94b75-34e9-420e-9c9b-d84ead5e74a8.pdf) |
| 2026-08-20 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e322e7b3-141f-48da-8e06-b9bc546fdb47.pdf) |
| 2026-08-20 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26e112ef-e3b7-45cb-b709-8570a7e0eb85.pdf) |
| 2026-07-28 | [ANNUAL REPORT FY 2025-26 - CONFIRM THAT ANNUAL REPORT EMAILED TO ALL SHAREHOLDERS RTA NSDL CDSL](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20fcf748-a592-4faf-ab48-64daee4a036c.pdf) |
| 2026-07-27 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86de3716-1100-4f14-aaaf-aa24039c8c8d.pdf) |
| 2026-07-27 | [NOTICE Of AGM Containing NOTES & Explanatory Statements Instructions & Details Resolutions E-Voting Scrutinizer Etc.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4dfff75-93bc-4107-842e-c0a6b59b6015.pdf) |
| 2026-07-20 | [Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 20.07.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b582741e-5d45-4e52-8267-a65dc2eac03b.pdf) |
| 2026-07-20 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f6d3e1c-50d6-4370-87a6-16f7bfcd7976.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-20 | [QUARTERLY RESULTS FOR QUARTER ENDED 30 JUNE 2026 ALONGWITH LIMITED REVIEW REPORT](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b86738a-792b-4fe3-af28-76cb6b999f52.pdf) |
| 2026-05-29 | [Audited Financial Results Of QUARTER & YEAR Ended 31.03.2026 And Year To Date Audited Financial Results From 01.04.2025 To 31.03.2026 Half-Yearly Statement Of Assets & Liabilities As At 31.03.2026 And Limited Review Audit Reports](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c0d838a-c858-4b32-9874-7ae1088a2a95.pdf) |
| 2026-05-29 | [Audited Annual Accounts For The FY Ended 31.03.2026 Alongwith Statutory Independent Audit Report Dated 29.05.2026 From Statutory Auditors.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6843a136-7c63-4368-ab9a-fa37491b4b87.pdf) |
| 2026-02-09 | [Un-Audited Financial Results Of Quarter & Nine-Months Ended 31.12.2025 Alongwith Limited Review Report From Statutory Auditors As Compliances U/Reg 33(3) Of SEBI(LODR) Stands Approved & Adopted.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98b43260-980b-4dc2-abea-b28244d16281.pdf) |
| 2025-11-14 | [Un-Audited Financial Results Of Quarter & Half-Year Ended 30.09.2025 Alongwith Half-Yearly Statement Of Assets & Liabilities And Cash Flow Statement As At 30.09.2025 And Limited Review Report From Statutory Auditors As Compliances U/Reg 3](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb5aa8dc-0ce1-4cee-a171-d96747d3f0e5.pdf) |
| 2025-08-01 | [Un-Audited Financial Results Of Quarter Ended 30.06.2025 Alongwith Limited Review Report From Statutory Auditors Stands Approved & Adopted.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=522ce242-9a62-43b2-baa8-ad7315e986f0.pdf) |
| 2025-05-27 | [Audited Annual Accounts For The FY Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee828236-5c97-490a-a621-7b12bd1378bc.pdf) |
| 2025-05-27 | [Audited Financial Results Of QUARTER & YEAR Ended 31.03.2025 And Alongwith Half-Yearly Statement Of Assets & Liabilities As At 31.03.2025 And Limited Review Audit Reports Of The Quarter & Year-To-Date From Statutory Auditors](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5e59f32-6a24-45bd-9fa1-584968bac06b.pdf) |
| 2025-02-14 | [Board Considered Approved & Adopted The Following Un-Audited Quarterly & Nine-Months Financial Results As On 31.12.2024 And We Hereby Submit & Enclose The Following As Compliances U/Reg 33(3) Of S](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae32b9b3-944b-42d4-aece-5696cd6a548d.pdf) |
| 2024-11-13 | [Board Considered, Approved & Adopted The Following Un-Audited Quarterly & Half-Yearly Financial Results As On 30.09.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff72f313-4de8-430d-966f-760915002e48.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Unaudited Q3 and nine-month results for 31.12.2025 approved; limited review attached; trading window closed Jan 1–Feb 15, 2026. | [Board Meeting Outcome for Outcome Of Board Meeting 09.02.2026 9 Feb - Unaudited Q3 and nine-month results for 31.12.2025 approved; limited review attached; trading window closed Jan 1–Feb 15, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2de4fb23-5b15-46f6-b51d-4f158f66c58e.pdf) |
| 7 Apr - FY2026 SAST disclosures filed on 4 Apr 2026; promoters reported no pledge and no shareholding change. | [Disclosure U/R 31(4) Of SEBI (SAST) Regulations, 2011 - PROMOTER 7 Apr - FY2026 SAST disclosures filed on 4 Apr 2026; promoters reported no pledge and no shareholding change.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bd476ca0-9510-4df1-9ea3-d8b097fdfd55.pdf) |
| 5 Feb - Newspaper Publication of Financial Results for Quarter and Nine months ended December 31, 2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 5 Feb - Newspaper Publication of Financial Results for Quarter and Nine months ended December 31, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d824e2b6-ebc4-4c4b-948f-cec3a5fb5e49.pdf) |
| 4 Feb - Board approved Q3 FY26 results (quarter loss Rs.661.95L); deposited Rs.4.22Cr for CCI penalty stay; acquired Medcuore for Rs.568.66L; CCPS Rs.850L. | [Board Meeting Outcome for Results For The Quarter And Nine Months Ended 31St December 2025 4 Feb - Board approved Q3 FY26 results (quarter loss Rs.661.95L); deposited Rs.4.22Cr for CCI penalty stay; acquired Medcuore for Rs.568.66L; CCPS Rs.850L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/27338350-5947-4b41-9ec4-15f5a4c49f64.pdf) |
| 31 Jan - Board meeting 09.02.2026 to approve unaudited Q3/9M results (31-12-2025); trading window 01.01–15.02.2026. | [Board Meeting Intimation for NOTICE / INTIMATION - BOARD MEETING - Regd. Office On MONDAY - 09.02.2026 At 11:30 A.M. 31 Jan - Board meeting 09.02.2026 to approve unaudited Q3/9M results (31-12-2025); trading window 01.01–15.02.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cfd21a9c-d78d-4de1-a30b-99b9de0d9dd2.pdf) |
| 3 Mar - CMO Shardul Bist resigns effective 31 March 2026; will support transition. | [Announcement under Regulation 30 (LODR)-Change in Management 3 Mar - CMO Shardul Bist resigns effective 31 March 2026; will support transition.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1c729c3f-c368-4fae-a040-1155b45c99a4.pdf) |
| 22 Jan - Subscribed Rs.6,93,66,540 for 54.79% of Medcuore; 7551 shares; now subsidiary. | [Announcement under Regulation 30 (LODR)-Acquisition 22 Jan - Subscribed Rs.6,93,66,540 for 54.79% of Medcuore; 7551 shares; now subsidiary.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8aeadeb8-76f8-466c-9e3b-e5f58d09514e.pdf) |
| 21 Jan - Submitted quarterly compliance filings for quarter ended 31-12-2025, including share audit, governance report, and certificates. | [REG 15 - NOT APPLICABLE - QTR 31.12.25 21 Jan - Submitted quarterly compliance filings for quarter ended 31-12-2025, including share audit, governance report, and certificates.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a5dc9422-b08f-474c-9ee8-de54206b3d5c.pdf) |
| 21 Jan - Investors' complaints status for quarter ended 31 Dec 2025: no complaints received, redressed, or pending. | [REG 13 - INVESTORS COMPLAINTS - QTR 31.12.2025 21 Jan - Investors' complaints status for quarter ended 31 Dec 2025: no complaints received, redressed, or pending.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9d19d86-cd5e-43c8-a5ef-05aba93e6bde.pdf) |
| 20 Jan - Board meeting 4 Feb 2026 to approve unaudited results for quarter ended Dec 31, 2025; trading window closed. | [Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 31St December, 2025 20 Jan - Board meeting 4 Feb 2026 to approve unaudited results for quarter ended Dec 31, 2025; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/78ca7b9e-b345-419c-8dfe-47b31caadbd9.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1750_NIPPOBATRY_2012_2013_13092013180507.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/86de3716-1100-4f14-aaaf-aa24039c8c8d.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ebf0d89-a81c-4c48-a29b-8f5f317f519c.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5f9b41ba-c3df-4113-883b-96339cbcc627.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a0d977b2-2229-4926-8e18-4389a93e5174.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d1839b72-634a-4bf8-bdee-e83a20012307.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d88f413f-4db2-4540-9463-eedfba6fa1d6.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bfa84cba-f711-46a8-8d82-bfafc71eac62.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/504058/75344504058.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539405/74744539405.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2021 | [Concall - Sep 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ec55fdac-4c9f-468b-bf93-ccac34164815.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:58:41.437Z.